Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts

NCT04994444 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Tobacco Use Cessation

Interventions

DRUG: Nicoderm CQ 21Mg/24Hr Transdermal System

Sponsor

Brown University

Collaborators

[object Object]